Medical technology portfolio company Medovex said today it won CE Mark approval in the European Union for its DenerveX spinal denervation treatment system designed to treat facet joint syndrome. The DenerveX system uses a slowly rotating burr to remove targeted facet joint synovial membrane and radiofrequency ablation technology to destroy tissue and denude any residual nervous […]
Orthopedics
Welcome to MassDevice's Orthopedics Hub, your resource for the latest in orthopedic news. Stay informed about the innovations and business news shaping the ortho device industry.
🦴 Narrow your focus with these categories:
Implants | Metal-on-Metal | Spine
Here are the top orthopedic device features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ The biggest stories from AAOS 2024
+ The 10 largest orthopedic device companies in the world
+ The ZimVie Tether helps kids with scoliosis — if they can get it in time
+ Could 2023 be a boom year for orthopedic devices?
+ The top orthopedic device news out of AAOS 2023
🎙️ Tune in to the Ortho Innovation Talks podcast on the DeviceTalks podcast network.
Latest Orthopedics News
NovoSource auction set for June 28
UPDATED Oct. 29, 2019, with statement from new NovoSource owner. Orthopedic device developer NovoSource is headed to the auction block later this month, with the company’s assets to be sold off to pay a creditor. The Dayton, Ohio-based medical device maker’s primary products were the NovoKnee total knee system and the NovoHip total hip system. In […]
N.J. consolidates Stryker Lfit hip lawsuits
The New Jersey Supreme Court approved a bid this week to consolidate state court lawsuits against Stryker (NYSE:SYK) over an allegedly defective hip replacement device. The company faces a barrage of lawsuits regarding its Lfit cobalt-chromium v40 femoral heads, including that the product corrodes when connected to a component part, which can necessitate corrective surgery. In […]
Arthromeda: Series D is enough for clinicals, approval bids
UPDATE: Updated to include information from an SEC filing. Arthromeda said yesterday that it closed a Series D round for an unspecified amount that’s enough to get its ArthroSight-PS hip replacement navigation platform through clinical trials and hoped-for regulatory approvals. The company has raised $1.5 million in a round of equity financing, with 10 anonymous investors taking part, […]
UPDATE: Medtronic recalls Kyphon bone cement device
Medtronic (NYSE:MDT) is recalling some of its Kyphon instruments that deliver bone cement after discovering a misalignment issue with the devices.* The Fridley, Minn.-based company sent a letter to customers last month detailing the issue with the Kyphon directional bone filler, saying it received 2 reports that “the directional arrow at the proximal end of […]
Aurora Spine shops licensing deal for polyaxial implant system
Aurora Spine (TSX:ASG.V) said today it will look for licensers for its proprietary polyaxial interspinous fusion implant locking system. The Carlsbad, Calif.-based company said that it will be looking for both industrial and medical applications for the patented tech, entitled polyaxial interspinous fusion implant and bone growth stimulation system. “Aurora Spine is now offering its new Polyaxial […]
Orthopedic synthetic polymer dev Hyalex Ortho raises $16m in Series A
Orthopedic synthetic polymer developer Hyalex Orthopaedics said today it raised $16 million in a Series A round of financing, with funds slated to support its Hyalex technology platform. The financing round was led by Canaan Partners and joined by Osage University Partners and Johnson & Johnson‘s (NYSE:JNJ) Innovation, JJDC Inc. Boston-based Hyalex is developing a […]
J&J’s DePuy Synthes touts 4-year Attune knee revision data
Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes today touted 4-year data from a large registry study showing that its Attune knee implant had a lower revision rate than the overall rate for total knee replacement. The study examined data from 10,605 Attune implantations in Britain’s National Joint Registry for England, Wales, Northern Ireland & the Isle of […]
InVivo adds Reeve Foundation database to Contempo registry study
InVivo Therapeutics (NSDQ:NVIV) said today it will integrate data from the Christopher & Dana Reeve Foundation’s North American Clinical Trials Network Registry in the Contempo registry study which is complementing its ongoing Inspire study. The Cambridge, Mass.-based company said that the Contempo study looks to provide comprehensive natural history benchmarks for the Inspire study of its […]
FDA labels Zimmer Biomet SpF spinal fusion stimulator recall as Class I
The FDA today released information on a Zimmer Biomet (NYSE:ZBH) recall of select SpF Plus-Mini and SpF XL IIB implantable spinal fusion stimulators over issues with potentially harmful chemicals which could be toxic to tissues and organs. Class I recall designations, the agency’s most serious classification of recall, are used when there is a reasonable probability […]
Anika launches late-stage supplemental Cingal study
Anika Therapeutics (NSDQ:ANIK) said yesterday that it enrolled the 1st patient in a supplemental Phase III efficacy and safety trial of its Cingal hyaluronic acid-corticosteroid combination viscosupplement. The Bedford, Mass.-bsaed company is evaluating Cingal as a treatment for osteoarthritis-related knee pain. Get the full story at our sister site, Drug Delivery Business News.